Monday, April 04, 2005

Alkermes submits alcoholism drug to FDA
APR. 1 11:15 A.M. ET Alkermes Inc. on Friday submitted an application to the Food and Drug Administration for marketing approval of a new drug that would treat alcohol dependence.

Vivitrex would be the first medication available for the treatment of alcohol dependence in a formulation that is administered once a month by injection. The drug is a new formulation of naltrexone, which reduces the desire for alcohol.